Newsletter Archive

1. 05.21.25 -- Do We Really Understand Plasmid Quality's Effects On mRNA Production? 5/21/2025
   05/21/25 Advancing RNA Newsletter
2. 05.20.25 -- Do Your IVT mRNA Products Meet The Necessary Quality Guidelines? 5/20/2025

   05/20/25 Advancing RNA Newsletter

3. 05.14.25 -- Alnylam On Commercializing RNAi Therapies 5/14/2025
   05/14/25 Advancing RNA Newsletter
4. 05.07.25 -- How To Reduce mRNA Production COGS 5/7/2025
   05/07/25 Advancing RNA Newsletter
5. 04.30.25 -- Plasmid Production: 3 Takeaways For mRNA Manufacturing 4/30/2025
   04/30/25 Advancing RNA Newsletter
6. 04.23.25 -- Establishing Analytical Methods For mRNA-Based Therapies 4/23/2025
   04/23/25 Advancing RNA Newsletter
7. 04.21.25 -- Bringing Your mRNA-Based Drug From Pre-Clinical To Commercial 4/21/2025
   04/21/25 Advancing RNA Newsletter
8. 04.16.25 -- Britney Spears/ Take On mRNA Platform Analytics 4/16/2025
   04/16/25 Advancing RNA Newsletter
9. 04.10.25 -- Navigating Clinical Trial Trends In 2025 4/10/2025

   04/10/25 Advancing RNA Newsletter

10. 04.09.25 -- Is The mRNA Payload The Real MVP Of Targeted Delivery? 4/9/2025
    04/09/25 Advancing RNA Newsletter